Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-01 Purchase |
2025-04-03 6:05 pm |
ALUMIS INC. | ALMS | Babler Martin President, CEO and Chairman |
15,650 | $6.4366 | $100,733 | 106,454 (Indirect) |
View |
| 2024-07-01 Sale |
2024-07-01 4:35 pm |
ALUMIS INC. | ALMS | Babler Martin President, CEO and Chairman |
90,804 | $0 | $0 | 2,491,762 (Indirect Direct) |
View |
| 2020-06-23 Sale |
2020-06-25 8:07 pm |
Principia Biopharma Inc. | PRNB | Babler Martin President, CEO |
15,000 | $61.86 | $927,889 | 144,072 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-18 Option Award |
2025-02-20 6:30 pm |
N/A 2035-02-17 |
ALUMIS INC. | ALMS | Babler Martin President, CEO and Chairman |
523,000 | $0 | 523,000 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 4:01 pm |
N/A 2035-02-03 |
89bio Inc. | ETNB | Babler Martin Director |
56,400 | $0 | 56,400 (Direct) |
View |
| 2024-06-27 Option Award |
2024-07-01 4:35 pm |
N/A 2034-06-26 |
ALUMIS INC. | ALMS | Babler Martin President, CEO and Chairman |
2,491,762 | $0 | 2,491,762 (Direct) |
View |
Ownership |
2024-06-27 4:02 pm |
N/A N/A |
ALUMIS INC. | ALMS | Babler Martin President, CEO and Chairman |
0 | $0 | 2,448,982 (Indirect) |
View |
| 2024-06-14 Option Award |
2024-06-18 4:11 pm |
N/A 2034-06-13 |
Prelude Therapeutics Inc | PRLD | Babler Martin Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2024-05-02 Option Award |
2024-05-03 4:01 pm |
N/A 2034-05-02 |
89bio Inc. | ETNB | Babler Martin Director |
67,700 | $0 | 67,700 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 4:11 pm |
N/A 2033-06-15 |
Prelude Therapeutics Inc | PRLD | Babler Martin Director |
23,500 | $0 | 23,500 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 4:24 pm |
N/A 2033-06-07 |
Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 4:13 pm |
N/A 2032-06-16 |
Prelude Therapeutics Inc | PRLD | Babler Martin Director |
31,293 | $0 | 31,293 (Direct) |
View |
| 2022-05-12 Option Award |
2022-05-16 6:22 pm |
N/A 2032-05-11 |
Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-20 8:30 pm |
N/A 2031-07-18 |
Prelude Therapeutics Inc | PRLD | Babler Martin Director |
36,400 | $0 | 36,400 (Direct) |
View |
| 2021-05-11 Option Award |
2021-05-13 5:36 pm |
N/A 2031-05-10 |
Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director |
25,000 | $0 | 25,000 (Direct) |
View |
Ownership |
2021-01-06 9:39 pm |
N/A N/A |
Omega Alpha SPAC | OMEG | Babler Martin Director |
0 | $0 | 35,000 (Direct) |
View |
| 2020-09-28 Equity Swap |
2020-09-28 5:07 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin President, CEO |
58,557 | $100 | 0 (Direct) |
View |
| 2020-09-08 Option Award |
2020-09-10 4:28 pm |
N/A 2030-09-08 |
Neoleukin Therapeutics Inc. | NLTX | Babler Martin Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-25 8:07 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Babler Martin President, CEO |
15,000 | $2.9977 | 144,072 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-25 8:07 pm |
N/A 2023-10-23 |
Principia Biopharma Inc. | PRNB | Babler Martin President, CEO |
15,000 | $0 | 144,072 (Direct) |
View |